PSUSA/00000426/201812 - periodic safety update report single assessment
Botulinum toxin a
PSUSA
Human
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Botulinum toxin a: List of nationally authorised medicinal products - PSUSA/00000426/201812
English (EN) (209.94 KB - PDF)
Botulinum toxin a: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00000426/201812
English (EN) (26.91 KB - PDF)
български (BG) (94.79 KB - PDF)
español (ES) (29.16 KB - PDF)
čeština (CS) (101.07 KB - PDF)
dansk (DA) (32.86 KB - PDF)
Deutsch (DE) (26.19 KB - PDF)
eesti keel (ET) (27.42 KB - PDF)
ελληνικά (EL) (95.57 KB - PDF)
français (FR) (32.24 KB - PDF)
hrvatski (HR) (89.49 KB - PDF)
íslenska (IS) (24.82 KB - PDF)
italiano (IT) (34.89 KB - PDF)
latviešu valoda (LV) (99.86 KB - PDF)
lietuvių kalba (LT) (95.89 KB - PDF)
magyar (HU) (88.69 KB - PDF)
Malti (MT) (101.42 KB - PDF)
Nederlands (NL) (31.87 KB - PDF)
norsk (NO) (56.31 KB - PDF)
polski (PL) (96.67 KB - PDF)
português (PT) (32.13 KB - PDF)
română (RO) (100.59 KB - PDF)
slovenčina (SK) (100.04 KB - PDF)
slovenščina (SL) (96.94 KB - PDF)
Suomi (FI) (25.89 KB - PDF)
svenska (SV) (32.05 KB - PDF)